Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

February 17, 2017

Primary Completion Date

April 24, 2017

Study Completion Date

April 24, 2017

Conditions
Diabetic Retinopathy
Interventions
PROCEDURE

Color fundus photography

Subjects will undergo fundus photography before and after administration of mydriatic agent.

DRUG

Mydriatic Agent

Subjects will be administered mydriatic medication to dilate their pupils.

Trial Locations (1)

90033

LAC+USC Medical Center, Los Angeles

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

Eyenuk, Inc.

INDUSTRY

NCT03078231 - Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool | Biotech Hunter | Biotech Hunter